Solventum Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SOLV research report →
Companywww.solventum.com
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.
- CEO
- Bryan C. Hanson
- IPO
- 2024
- Employees
- 22,000
- HQ
- Maplewood, MN, US
Price Chart
Valuation
- Market Cap
- $13.18B
- P/E
- 9.26
- P/S
- 1.60
- P/B
- 2.67
- EV/EBITDA
- 6.42
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 53.67%
- Op Margin
- 25.54%
- Net Margin
- 17.33%
- ROE
- 30.71%
- ROIC
- 15.87%
Growth & Income
- Revenue
- $8.32B · 0.86%
- Net Income
- $1.56B · 224.84%
- EPS
- $8.94 · 222.74%
- Op Income
- $2.18B
- FCF YoY
- -101.24%
Performance & Tape
- 52W High
- $88.20
- 52W Low
- $62.38
- 50D MA
- $68.19
- 200D MA
- $73.85
- Beta
- 0.66
- Avg Volume
- 1.68M
Get TickerSpark's AI analysis on SOLV
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | ALBAN CARLOS | other | 3,300 |
| May 15, 26 | COX CARRIE SMITH | other | 4,848 |
| May 15, 26 | DeVore Susan D. | other | 3,300 |
| May 15, 26 | Edwards Shirley Ann | other | 3,300 |
| May 15, 26 | EISENBERG GLENN A | other | 3,300 |
| May 15, 26 | Harris Bernard A Jr | other | 3,300 |
| May 15, 26 | MAY KAREN J | other | 3,300 |
| May 15, 26 | Mily Elizabeth | other | 3,300 |
| May 15, 26 | WEILAND JOHN H | other | 3,300 |
| May 15, 26 | Wendell Amy McBride | other | 3,300 |
Our SOLV Coverage
We haven't published any research on SOLV yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SOLV Report →